News

Back to News Items

August 2012: New Article: Liraglutide Is an Efficacious Treatment for Type 2 Diabetes

Main Bullet points:

* Liraglutide is a glucagon-like-peptide-1 (GLP-1) receptor agonist.

* As a once daily injection, Liraglutide has proven to be effectual at lowering blood sugar  and inducing weight loss in 

  patients.

* 51% of patients who received the 1.8 milligram doses of Liraglutide reached a target HbA1c level of less than 7.0%, which

   is the American 

* Diabetes Association target HbA1c level.

* Type 2 diabetes mellitus affects approximately 24 million people in the United States, and it is the leading cause of kidney

   failure and blindness.

* Numbers of people with type 2 diabetes are expected to increase worldwide due to the obesity epidemic.

 

 

Dun and Bradstreet